Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

CNBX Pharmaceuticals (CNBX) Long-Term Debt Repayments (2017 - 2018)

CNBX Pharmaceuticals (CNBX) has disclosed Long-Term Debt Repayments for 1 consecutive years, with $22000.0 as the latest value for Q4 2017.

  • For the quarter ending Q4 2017, Long-Term Debt Repayments changed N/A year-over-year to $22000.0, compared with a TTM value of $22000.0 through Aug 2018, changed N/A, and an annual FY2018 reading of $22000.0, changed N/A over the prior year.
  • Long-Term Debt Repayments was $22000.0 for Q4 2017 at CNBX Pharmaceuticals, up from -$589.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $22000.0 in Q4 2017 and bottomed at -$589.0 in Q3 2017.